Azitromicin Belupo 250 mg filmom obložene tablete

Name	Azitromicin Belupo 250 mg filmom obložene tablete
Marketing Authorisation Number	HR-H-162267682
Active Substance	azitromicin dihidrat
Composition	jedna filmom obložena tableta sadrži 250 mg azitromicina u obliku azitromicin dihidrata
Pharmaceutical Form	filmom obložena tableta
Manufacturer	Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska
Marketing Authorisation Holder	Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska
Marketing Authorisation Date	27.11.2019
MA Period of Validity	unlimited
Classification Number	UP/I-530-09/18-02/240
Registration Number	381-12-01/70-19-03
Prescription	Medicinal product subject to medical prescription
Type of prescription	Medicinal product on medical prescription for non-renewable delivery
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	J01FA10
Marketing status	Marketed
Shortage status	No shortage
SmPC	download
PL	download

Packaging

Packaging description	MA Number for Packaging	Marketing status	Shortage status
6 tableta u blisteru, u kutiji	HR-H-162267682-01	Marketed	No shortage

Direct Healthcare Professional Communication

Name	Date	Download
Pismo zdravstvenim radnicima o povećanoj stopi recidiva hematoloških maligniteta i smrtnosti kod bolesnika podvrgnutih transplantaciji hematopoetskih matičnih stanica (HSCT) liječenih azitromicinom	02.05.2018	Belupo lijekovi i kozmetika, Jadran – Galenski Laboratorij d.d., Krka-Farma d.o.o., PharmaS d.o.o., Pliva Hrvatska d.o.o. i Sandoz d.o.o.